On Feb. 21st 2019, Dr. Joanne Ho provided this in-person and online presentation where she discussed the pharmacology of cannabinoids, unique considerations for older adults and cannabis drug-drug interactions to consider with cannabinoids. Please note that the content included was based on the best evidence available at the time. The recording of the presentation is available for viewing here. A special edition reading list is available as a pdf featuring related resources.
This publication summarizes the literature on the evidence of using endocannabinoid system medications and their ability to modulate neuroinflammation and oxidative stress in Alzheimer’s Disease. 15 pages. Last reviewed March 2019.
The authors described the findings of a cross-sectional study which provided empirical evidence that prolonged use of inhaled or ingested street cannabis in patients with MS is associated with poorer performance on cognitive domains commonly affected in this population. 8 pages. Last reviewed March 2019.
This publication describes the findings of a review of medical marijuana (1948-2013) to address treatment of symptoms of multiple sclerosis (MS), epilepsy and movement disorders. 8 pages. Last reviewed March 2019.
This article reviews the findings of a randomized, double-blind, placebo-controlled study that sought evidence for the efficacy of low-dose TCH in reducing neuropsychiatric symptoms of dementia. 9 pages. Last reviewed March 2019.
This article provides a review of epidemiological findings focusing on illicit drug use disorders and nonmedical use of prescription drugs in older adults 50 years and older. 20 pages. Last reviewed March 2019.